Viewing Study NCT03518060


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2025-12-26 @ 12:28 AM
Study NCT ID: NCT03518060
Status: COMPLETED
Last Update Posted: 2024-10-16
First Post: 2018-04-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Dolutegravir/Rilpivirine, Antiretroviral Efficacy Study Using Real-world Data in Subjects With Human Immunodeficiency Virus (HIV)-1
Sponsor: ViiV Healthcare
Organization: